Development and in vitro characterization of polymeric nanoparticles containing recombinant adrenomedullin-2 intended for therapeutic angiogenesis-Reference-Cited by-同舟云学术

Development and in vitro characterization of polymeric nanoparticles containing recombinant adrenomedullin-2 intended for therapeutic angiogenesis

Published:2020-02 Issue: Volume:576 Page:118997
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Quadros Helenita Costa,Santos Laís de Macêdo Ferreira,Meira Cássio Santana,Khouri Mariana Ivo,Mattei Bruno,Soares Milena Botelho Pereira,de Castro-Borges William,Farias Leonardo Paiva,Formiga Fabio Rocha

Funder

Fundação de Amparo à Pesquisa do Estado da Bahia

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference38 articles.

1. Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres;Araújo;Colloids Surfaces B Biointerfaces,2009

2. DLS and zeta potential - What they are and what they are not?;Bhattacharjee;J. Control. Release,2016

3. Medication adherence: A call for action;Bosworth;Am. Heart J.,2011

4. Targeted delivery of nanopartides bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis;Chappell;Small,2008

5. Intermedin1–53 enhances angiogenesis and attenuates adverse remodeling following myocardial infarction by activating AMP-activated protein kinase;Chen;Mol. Med. Rep.,2017

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro anti-trypanosomal activity of 3-(aryl)-6-piperazin1,2,4-triazolo[3,4-a]phthalazines-loaded ultrathin polymeric particles: effect of polymer type and particle size;RSC Pharmaceutics;2024

2. Decrypting the role of angiogenesis, inflammation, and oxidative stress in pathogenesis of congestive heart failure: Nanotechnology as a boon for the management of congestive heart failure;Targeting Angiogenesis, Inflammation, and Oxidative Stress in Chronic Diseases;2024

3. Advanced Drug Delivery Micro- and Nanosystems for Cardiovascular Diseases;Molecules;2022-09-09

4. Tissue response and retention of micro- and nanosized liposomes in infarcted mice myocardium after ultrasound-guided transthoracic injection;European Journal of Pharmaceutics and Biopharmaceutics;2022-04

5. Polymeric nanoparticles in the diagnosis and treatment of myocardial infarction: Challenges and future prospects;Materials Today Bio;2022-03